• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与门诊患者相比,在多发性硬化症中心接受随访的患者更早出现残疾。

Earlier disability of the patients followed in Multiple Sclerosis centers compared to outpatients.

作者信息

Debouverie M, Laforest L, Van Ganse E, Guillemin F

机构信息

Department of Neurology, Central Hospital, Nancy, France.

出版信息

Mult Scler. 2009 Feb;15(2):251-7. doi: 10.1177/1352458508097919.

DOI:10.1177/1352458508097919
PMID:19181774
Abstract

OBJECTIVE

The currently published works regarding the multiple sclerosis (MS) natural history report data were collected most often on population of patients recruited in MS centers. The aim was to compare the natural history of a population of patients followed in a MS centre (MSC) with patients followed outside a MS centre (NMSC).

METHODS

Cases were identified through the LORSEP cohort, a network of neurologists (private ambulatory practice, hospitals, and MS centers) in France.

RESULTS

A total of 3602 patients had been analyzed: 1036 MSC patients and 2566 NMSC patients. No difference was observed regarding gender and initial symptoms. Conversely, MSC patients were younger at MS onset and were more likely to have a primary progressive initial form. Median times (years) to the EDSS scores of 3, 4, and 6 were 5.8 (5.0-6.8), 8.4 (7.9-9.0), 16.0 (14.8-18.1) in the MSC group, respectively, whereas corresponding times were 8.4 (7.9-9.0), 12.3 (11.4-13.4), 19.1 (18.0-20.2) in the NMSC group. These differences according to the type of MS supervision were statistically significant for EDSS3 (P < 0.0001), EDSS4 (P < 0.0001), and EDSS6 (P = 0.01), respectively. These findings were confirmed in Cox multivariate models.

CONCLUSIONS

The patients followed in a MS centre had earlier disability than patients managed otherwise. Analyses exclusively conducted in patients with MS supervised in specialized centers may falsely misestimate the times needed to reach major disability landmarks. Before using registries to study the natural history of MS, efforts should be performed to verify in how far data are exhaustive and to understand the local health care system.

摘要

目的

目前已发表的关于多发性硬化症(MS)自然史的研究报告数据大多收集自MS中心招募的患者群体。本研究旨在比较在MS中心(MSC)接受随访的患者群体与在MS中心以外(NMSC)接受随访的患者群体的自然史。

方法

通过LORSEP队列识别病例,LORSEP队列是法国的一个由神经科医生组成的网络(私人门诊、医院和MS中心)。

结果

共分析了3602例患者:1036例MSC患者和2566例NMSC患者。在性别和初始症状方面未观察到差异。相反,MSC患者在MS发病时更年轻,且更有可能具有原发进展型初始形式。在MSC组中,EDSS评分达到3、4和6的中位时间(年)分别为5.8(5.0 - 6.8)、8.4(7.9 - 9.0)、16.0(14.8 - 18.1),而在NMSC组中相应时间分别为8.4(7.9 - 9.0)、12.3(11.4 - 13.4)、19.1(18.0 - 20.2)。根据MS监测类型的这些差异,对于EDSS3(P < 0.0001)、EDSS4(P < 0.0001)和EDSS6(P = 0.01)分别具有统计学意义。这些发现在Cox多变量模型中得到证实。

结论

在MS中心接受随访的患者比其他方式管理的患者更早出现残疾。仅在专业中心接受MS监测的患者中进行的分析可能会错误地高估达到主要残疾里程碑所需的时间。在使用登记处研究MS的自然史之前,应努力核实数据的详尽程度,并了解当地的医疗保健系统。

相似文献

1
Earlier disability of the patients followed in Multiple Sclerosis centers compared to outpatients.与门诊患者相比,在多发性硬化症中心接受随访的患者更早出现残疾。
Mult Scler. 2009 Feb;15(2):251-7. doi: 10.1177/1352458508097919.
2
How effective are disease-modifying drugs in delaying progression in relapsing-onset MS?疾病修正药物在延缓复发型多发性硬化症进展方面的效果如何?
Neurology. 2007 Oct 9;69(15):1498-507. doi: 10.1212/01.wnl.0000271884.11129.f3. Epub 2007 Aug 15.
3
Progression in familial and nonfamilial MS.家族性和非家族性多发性硬化症的进展
Mult Scler. 2008 Apr;14(3):300-6. doi: 10.1177/1352458507084269. Epub 2008 Jan 21.
4
Natural history of secondary-progressive multiple sclerosis.继发进展型多发性硬化的自然史。
Mult Scler. 2008 Apr;14(3):314-24. doi: 10.1177/1352458507084264. Epub 2008 Jan 21.
5
Natural history of multiple sclerosis: a unifying concept.多发性硬化症的自然史:一个统一的概念。
Brain. 2006 Mar;129(Pt 3):606-16. doi: 10.1093/brain/awl007. Epub 2006 Jan 16.
6
Utilization of health care by patients with multiple sclerosis is based on professional and patient-defined health needs.患有多发性硬化症的患者对医疗保健的利用基于专业人员和患者确定的健康需求。
Mult Scler. 2008 Nov;14(9):1269-79. doi: 10.1177/1352458508094884. Epub 2008 Jul 24.
7
The long-term cost of multiple sclerosis in France and potential changes with disease-modifying interventions.法国多发性硬化症的长期成本及疾病修饰干预带来的潜在变化。
Mult Scler. 2009 Jun;15(6):741-51. doi: 10.1177/1352458509102771. Epub 2009 Apr 21.
8
The natural history of primary progressive multiple sclerosis.原发性进行性多发性硬化症的自然病史。
Neurology. 2009 Dec 8;73(23):1996-2002. doi: 10.1212/WNL.0b013e3181c5b47f.
9
Sunlight exposure and sun sensitivity associated with disability progression in multiple sclerosis.光照暴露和对阳光的敏感与多发性硬化症的残疾进展有关。
Mult Scler. 2012 Apr;18(4):451-9. doi: 10.1177/1352458511423778. Epub 2011 Sep 27.
10
Increased relapse rate in pediatric-onset compared with adult-onset multiple sclerosis.与成人起病的多发性硬化症相比,儿童起病的多发性硬化症复发率更高。
Arch Neurol. 2009 Jan;66(1):54-9. doi: 10.1001/archneurol.2008.505.

引用本文的文献

1
Barriers to clinical follow-up visits in multiple sclerosis: A nationwide register-based study.多发性硬化症临床随访的障碍:一项基于全国登记系统的研究。
Mult Scler J Exp Transl Clin. 2024 Dec 18;10(4):20552173241307619. doi: 10.1177/20552173241307619. eCollection 2024 Oct-Dec.
2
No Increase in Symptoms Toward the End of the Ocrelizumab Infusion Cycle in Patients With Multiple Sclerosis: Symptom Burden on Ocrelizumab: A Longitudinal Study (SymBOLS).多发性硬化症患者在奥瑞珠单抗输注周期结束时症状无增加:奥瑞珠单抗的症状负担:一项纵向研究(SymBOLS)
Neurol Clin Pract. 2023 Oct;13(5):e200185. doi: 10.1212/CPJ.0000000000200185. Epub 2023 Sep 5.
3
Use of healthcare services by patients with multiple sclerosis in France over 2010-2015: a nationwide population-based study using health administrative data.
2010 - 2015年法国多发性硬化症患者的医疗服务使用情况:一项基于全国人口的使用卫生行政数据的研究。
Mult Scler J Exp Transl Clin. 2019 Dec 18;5(4):2055217319896090. doi: 10.1177/2055217319896090. eCollection 2019 Oct-Dec.
4
Long-term evolution of multiple sclerosis disability in the treatment era.治疗时代多发性硬化症残疾的长期演变。
Ann Neurol. 2016 Oct;80(4):499-510. doi: 10.1002/ana.24747. Epub 2016 Aug 13.
5
A population-based study comparing multiple sclerosis clinic users and non-users in British Columbia, Canada.一项基于人群的研究,比较了加拿大不列颠哥伦比亚省多发性硬化症诊所的使用者和非使用者。
Eur J Neurol. 2016 Jun;23(6):1093-100. doi: 10.1111/ene.12990. Epub 2016 Mar 15.
6
No prognostic value of routine cerebrospinal fluid biomarkers in a population-based cohort of 407 multiple sclerosis patients.在一个基于人群的407例多发性硬化症患者队列中,常规脑脊液生物标志物无预后价值。
BMC Neurol. 2015 May 13;15:79. doi: 10.1186/s12883-015-0330-4.